Cash Flow Statement

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Synopsys Inc., consolidated cash flow statement

US$ in thousands

12 months ended:	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020	Oct 31, 2019
Net income	2,235,810)	1,218,125)	978,436)	756,359)	663,447)	532,367)
Amortization and depreciation	295,065)	247,120)	228,405)	203,676)	209,986)	201,676)
Reduction of operating lease right-of-use assets	97,273)	97,705)	89,541)	86,645)	82,895)	—)
Amortization of capitalized costs to obtain revenue contracts	73,587)	82,190)	73,026)	64,698)	61,185)	62,750)
Stock-based compensation	692,316)	563,292)	459,029)	345,272)	248,584)	155,001)
Allowance for credit losses	19,724)	19,932)	(3,477)	18,515)	20,875)	11,669)
Gain on sale of strategic investments	(55,077)	—)	—)	—)	—)	—)
Gain on divestitures, net of transaction costs	(868,830)	—)	—)	—)	—)	—)
Amortization of bridge financing costs	33,677)	—)	—)	—)	—)	—)
Deferred income taxes	(407,649)	(211,045)	(36,913)	(128,583)	(111,526)	(82,620)
Other	(1,295)	13,295)	10,188)	15,859)	4,325)	(4,052)
Accounts receivable	(103,460)	(178,432)	(251,390)	201,706)	(236,806)	(8,575)
Inventories	(51,449)	(123,752)	1,320)	(48,046)	(55,024)	(19,243)
Prepaid and other current assets	(410,432)	(106,396)	(89,983)	(102,174)	(11,298)	(49,779)
Other long-term assets	(168,255)	(100,618)	(15,283)	(153,037)	(83,367)	(124,895)
Accounts payable and accrued liabilities	187,564)	170,496)	(34,066)	125,133)	113,773)	(19,280)
Operating lease liabilities	(96,966)	(73,281)	(85,828)	(82,581)	(78,578)	—)
Income taxes	(73,215)	198,078)	1,644)	28,855)	14,120)	19,777)
Deferred revenue	8,641)	(113,435)	414,251)	160,325)	148,722)	125,717)
Net changes in operating assets and liabilities, net of effects from acquisitions and dispositions	(707,572)	(327,340)	(59,335)	130,181)	(188,458)	(76,278)
Adjustments to reconcile net income to net cash provided by operating activities	(828,781)	485,149)	760,464)	736,263)	327,866)	268,146)
Net cash provided by operating activities	1,407,029)	1,703,274)	1,738,900)	1,492,622)	991,313)	800,513)
Proceeds from maturities and sales of short-term investments	138,961)	130,435)	93,696)	12,850)	—)	—)
Purchases of short-term investments	(136,821)	(131,079)	(97,245)	(161,732)	—)	—)
Proceeds from sales of strategic investments	55,696)	8,492)	582)	—)	2,151)	6,361)
Purchases of strategic investments	(1,293)	(435)	(7,000)	(7,591)	(2,762)	(3,245)
Purchases of property and equipment, net	(123,161)	(189,618)	(136,589)	(93,764)	(154,717)	(198,129)
Acquisitions, net of cash acquired	(156,947)	(297,692)	(422,374)	(296,017)	(201,045)	(36,605)
Proceeds from business divestiture, net of cash divested	1,446,578)	—)	—)	—)	—)	—)
Capitalization of software development costs	—)	(2,204)	(2,493)	(1,976)	(4,045)	(4,259)
Other	—)	—)	(1,200)	(800)	—)	—)
Net cash (used in) provided by investing activities	1,223,013)	(482,101)	(572,623)	(549,030)	(360,418)	(235,877)
Proceeds from credit facilities	—)	—)	—)	—)	276,489)	192,897)
Repayment of debt	(2,607)	(2,603)	(76,838)	(28,061)	(288,879)	(524,063)
Payment of bridge financing and term loan costs	(72,265)	—)	—)	—)	—)	—)
Issuances of common stock	232,212)	252,986)	237,956)	210,719)	197,403)	156,364)
Payments for taxes related to net share settlement of equity awards	(337,541)	(241,408)	(174,005)	(138,950)	(82,225)	(57,143)
Purchase of equity forward contract	—)	(45,000)	—)	(35,000)	—)	—)
Purchases of treasury stock	—)	(1,160,724)	(1,100,000)	(753,081)	(242,078)	(329,185)
Other	(1,096)	(122)	(3,413)	(4,375)	(1,316)	(762)
Net cash used in financing activities	(181,297)	(1,196,871)	(1,116,300)	(748,748)	(140,606)	(561,892)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	8,797)	(2,979)	(65,296)	2,369)	17,154)	2,782)
Net change in cash, cash equivalents and restricted cash	2,457,542)	21,323)	(15,319)	197,213)	507,443)	5,526)
Cash, cash equivalents and restricted cash, beginning of year	1,441,187)	1,419,864)	1,435,183)	1,237,970)	730,527)	725,001)
Cash, cash equivalents and restricted cash, end of year	3,898,729)	1,441,187)	1,419,864)	1,435,183)	1,237,970)	730,527)

Based on: 10-K (reporting date: 2024-10-31), 10-K (reporting date: 2023-10-31), 10-K (reporting date: 2022-10-31), 10-K (reporting date: 2021-10-31), 10-K (reporting date: 2020-10-31), 10-K (reporting date: 2019-10-31).

Download chart

Cash flow statement item	Description	The company
Net cash provided by operating activities	Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.	Synopsys Inc. net cash provided by operating activities decreased from 2022 to 2023 and from 2023 to 2024.
Net cash (used in) provided by investing activities	Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.	Synopsys Inc. net cash (used in) provided by investing activities increased from 2022 to 2023 and from 2023 to 2024.
Net cash used in financing activities	Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.	Synopsys Inc. net cash used in financing activities decreased from 2022 to 2023 but then increased from 2023 to 2024 exceeding 2022 level.

Synopsys Inc. (NASDAQ:SNPS)

Cash Flow Statement